[Prevention of GI bleeding due to antiplatelet agents: a labyrinth!]

Presse Med. 2009 Dec;38(12):1722-6. doi: 10.1016/j.lpm.2009.09.011. Epub 2009 Nov 13.
[Article in French]
No abstract available

Publication types

  • Comparative Study
  • Editorial
  • Review

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles / therapeutic use
  • Aspirin / adverse effects*
  • Aspirin / therapeutic use
  • Clopidogrel
  • Drug Interactions
  • Drug Therapy, Combination
  • Gastrointestinal Hemorrhage / chemically induced*
  • Gastrointestinal Hemorrhage / prevention & control*
  • Humans
  • Lansoprazole
  • Omeprazole / therapeutic use
  • Pantoprazole
  • Platelet Aggregation / drug effects
  • Platelet Aggregation Inhibitors / adverse effects*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Proton Pump Inhibitors / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Ticlopidine / adverse effects
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / therapeutic use

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Platelet Aggregation Inhibitors
  • Proton Pump Inhibitors
  • Lansoprazole
  • Clopidogrel
  • Pantoprazole
  • Omeprazole
  • Ticlopidine
  • Aspirin